George W. Lloyd - May 26, 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role: EVP, Investments & GC
Signature: /s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
Stock symbol: RPRX
Transactions as of: May 26, 2022
Transactions value $: -$4,029,091
Form type: 4
Date filed: 5/31/2022, 05:19 PM
Previous filing: May 25, 2022
Next filing: Jul 27, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPRX	Class A Ordinary Shares	Sale	-$3.46M	-86K	-16.23%	$40.21	444K	May 26, 2022	By GWL 2014 G, LLC	F1
transaction	RPRX	Class A Ordinary Shares	Sale	-$570K	-14K	-3.15%	$40.77	430K	May 27, 2022	By GWL 2014 G, LLC	F2
holding	RPRX	Class A Ordinary Shares						496K	May 26, 2022	By GWL 2013 NG, LLC
holding	RPRX	Class A Ordinary Shares						240K	May 26, 2022	By GWL 2020 G, LLC
holding	RPRX	Class A Ordinary Shares						3K	May 26, 2022	Direct
holding	RPRX	Class A Ordinary Shares						274K	May 26, 2022	By IRA
holding	RPRX	Class A Ordinary Shares						4.01K	May 26, 2022	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.26 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.67 to $40.89 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.26 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.67 to $40.89 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.